International Diabetes Federation: An update of the evidence concerning the prevention of type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 87, Issue 2, 2010, Pages 143-149

  Simmons, R K ^a   Unwin, N ^b   Griffin, S J ^a  

^a MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cost effectiveness; Population based; Prevention; Screening; Type 2 diabetes

Indexed keywords

ORAL ANTIDIABETIC AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMMUNITY CARE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEART INFARCTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY PREVENTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCREENING TEST;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; MASS SCREENING; META-ANALYSIS AS TOPIC; PROPORTIONAL HAZARDS MODELS; RISK; RISK FACTORS;

EID: 74449092725     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.10.003     Document Type: Review

References (50)

1. Alberti K.G., Zimmet P., and Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabet. Med. 24 May (5) (2007) 451-463
2. Simmons R.K., Griffin S.J., and Wareham N.J. Researching how to realize the potential of diabetes prevention. Diabet. Med. 24 October (10) (2007) 1055-1057
3. Gillies C.L., Abrams K.R., Lambert P.C., Cooper N.J., Sutton A.J., Hsu R.T., et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334 February (7588) (2007) 299
4. Lindstrom J., Ilanne-Parikka P., Peltonen M., Aunola S., Eriksson J.G., Hemio K., et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368 November (9548) (2006) 1673-1679
5. Li G., Zhang P., Wang J., Gregg E.W., Yang W., Gong Q., et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371 May (9626) (2008) 1783-1789
6. Absetz P., Valve R., Oldenburg B., Heinonen H., Nissinen A., Fogelholm M., et al. Type 2 diabetes prevention in the "real world": one-year results of the GOAL Implementation Trial. Diabetes Care 30 October (10) (2007) 2465-2470
7. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344 May (18) (2001) 1343-1350
8. Lindstrom J., and Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26 March (3) (2003) 725-731
9. Kilkkinen A., Heistaro S., Laatikainen T., Janus E., Chapman A., Absetz P., et al. Prevention of type 2 diabetes in a primary health care setting. Interim results from the Greater Green Triangle (GGT) diabetes prevention project. Diabetes Res. Clin. Pract. 76 June (3) (2007) 460-462
10. Prevent Diabetes, Live Life Well project. http://www.livelifewell.nsw.gov.au/livelifewell/diabetes/index.html.
11. Ackermann R.T., Finch E.A., Brizendine E., Zhou H., and Marrero D.G. Translating the diabetes prevention program into the community. The DEPLOY Pilot Study. Am. J. Prev. Med. 35 October (4) (2008) 357-363
12. Lipscomb E.R., Finch E.A., Brizendine E., Saha C.K., Hays L.M., and Ackermann R.T. Reduced 10-year risk of coronary heart disease in patients who participated in a community-based diabetes prevention program: the DEPLOY Pilot Study. Diabetes Care 32 March (3) (2009) 394-396
13. Rosal M.C., Benjamin E.M., Pekow P.S., Lemon S.C., and von Goeler D. Opportunities and challenges for diabetes prevention at two community health centers. Diabetes Care 31 February (2) (2008) 247-254
14. Victora C.G., Habicht J.P., and Bryce J. Evidence-based public health: moving beyond randomized trials. Am. J. Public Health 94 March (3) (2004) 400-405
15. Ruge T., Nystrom L., Lindahl B., Hallmans G., Norberg M., Weinehall L., et al. Recruiting high-risk individuals to a diabetes prevention program: how hard can it be?. Diabetes Care 30 July (7) (2007) e61
16. Ackermann R.T., Marrero D.G., Hicks K.A., Hoerger T.J., Sorensen S., Zhang P., et al. An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes. Diabetes Care 29 June (6) (2006) 1237-1241
17. Finnish Diabetes Association, The development programme for the prevention and care of diabetes in Finland 2000-2010 (DEHKO).
18. Schwarz P.E., Lindstrom J., Kissimova-Scarbeck K., Szybinski Z., Barengo N.C., Peltonen M., et al. The European perspective of type 2 diabetes prevention: diabetes in Europe-prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Exp. Clin. Endocrinol. Diabetes 116 March (3) (2008) 167-172
19. NHS. www.nhs.uk/Change4Life (2009).
20. Unal B., Critchley J.A., and Capewell S. Small changes in United Kingdom cardiovascular risk factors could halve coronary heart disease mortality. J. Clin. Epidemiol. 58 July (7) (2005) 733-740
21. Hill J.O. Can a small-changes approach help address the obesity epidemic? A report of the joint task force of the American Society for Nutrition, Institute of Food Technologists, and International Food Information Council. Am. J. Clin. Nutr. 89 February (2) (2009) 477-484
22. Simmons R.K., Harding A.H., Jakes R.W., Welch A., Wareham N.J., and Griffin S.J. How much might achievement of diabetes prevention behaviour goals reduce the incidence of diabetes if implemented at the population level?. Diabetologia 49 May (5) (2006) 905-911
23. Ramachandran S., French J.M., Vanderpump M.P., Croft P., and Neary R.H. Using the Framingham model to predict heart disease in the United Kingdom: retrospective study. BMJ 320 March (7236) (2000) 676-677
24. Gillies C.L., Lambert P.C., Abrams K.R., Sutton A.J., Cooper N.J., Hsu R.T., et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 336 May (7654) (2008) 1180-1185
25. Goyder E.C. Screening for and prevention of type 2 diabetes. BMJ 336 May (7654) (2008) 1140-1141
26. Hoerger T.J., Hicks K.A., Sorensen S.W., Herman W.H., Ratner R.E., Ackermann R.T., et al. Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults. Diabetes Care 30 November (11) (2007) 2874-2879
27. Ramachandran A., Snehalatha C., Yamuna A., Mary S., and Ping Z. Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP). Diabetes Care 30 October (10) (2007) 2548-2552
28. Woolf S.H. A closer look at the economic argument for disease prevention. JAMA 301 February (5) (2009) 536-538
29. Lauritzen T., Griffin S., Borch-Johnsen K., Wareham N.J., Wolffenbuttel B.H., and Rutten G. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int. J. Obes. Relat. Metab. Disord. 24 September (Suppl. 3) (2000) S6-S11
30. Echouffo-Tcheugui J.B., Sargeant L.A., Prevost A.T., Williams K.M., Barling R.S., Butler R., et al. How much might cardiovascular risk be reduced by intensive therapy in people with screen-detected diabetes?. Diabet. Med. 25 (2008) 1433-1439
31. Sandbaek A., Griffin S.J., Rutten G., Davies M., Stolk R., Khunti K., Borch-Johnsen K., Wareham N.J., and Lauritzen T. Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease: the ADDITION study. Diabetologia 51 7 (2008) 1127-1134
32. Griffin S., Wareham N.J., Kinmoth A.L., Prevost T., Barling R., and Williams K. Does Intensive Treatment of Screen-detected Diabetes Improve Outcomes? One year Impact on Cardiovascular Risk Factors in the ADDITION (Cambridge) Trial (2007), European Association for the Study of Diabetes, Amsterdam, Netherlands
33. Janssen P.G., Gorter K.J., Stolk R.P., and Rutten G.E. Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study. Br. J. Gen. Pract. 59 January (558) (2009) 43-48
34. Eborall H., Davies R., Kinmonth A.L., Griffin S., and Lawton J. Patients' experiences of screening for type 2 diabetes: prospective qualitative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ 335 September (7618) (2007) 490
35. Eborall H.C., Griffin S.J., Prevost A.T., Kinmonth A.L., French D.P., and Sutton S. Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ 335 September (7618) (2007) 486
36. Goyder E., Wild S., Fischbacher C., Carlisle J., and Peters J. Evaluating the impact of a national pilot screening programme for type 2 diabetes in deprived areas of England. Fam. Pract. 25 October (5) (2008) 370-375
37. DOH, Putting Prevention First, Vascular checks: risk assessment and management, London, 2008.
38. Levitan E.B., Song Y., Ford E.S., and Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch. Intern. Med. 164 October (19) (2004) 2147-2155
39. Selvin E., Marinopoulos S., Berkenblit G., Rami T., Brancati F.L., Powe N.R., et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann. Intern. Med. 141 September (6) (2004) 421-431
40. Gerstein H.C., Miller M.E., Byington R.P., Goff Jr. D.C., Bigger J.T., Buse J.B., et al. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358 June (24) (2008) 2545-2559
41. ADVANCE. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 358 June (24) (2008) 2560-2572
42. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360 January (2) (2009) 129-139
43. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., and Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359 October (15) (2008) 1577-1589
44. Skyler J.S., Bergenstal R., Bonow R.O., Buse J., Deedwania P., Gale E.A., et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 32 January (1) (2009) 187-192
45. Ilanne-Parikka P., Eriksson J.G., Lindstrom J., Peltonen M., Aunola S., Hamalainen H., et al. Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study. Diabetes Care 31 April (4) (2008) 805-807
46. Deedwania P., Kosiborod M., Barrett E., Ceriello A., Isley W., Mazzone T., et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117 March (12) (2008) 1610-1619
47. Kohro T., Furui Y., Mitsutake N., Fujii R., Morita H., Oku S., et al. The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome. Int. Heart J. 49 March (2) (2008) 193-203
48. Wong T.Y., Liew G., Tapp R.J., Schmidt M.I., Wang J.J., Mitchell P., et al. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 371 March (9614) (2008) 736-743
49. Balagopal P., Kamalamma N., Patel T.G., and Misra R. A community-based diabetes prevention and management education program in a rural village in India. Diabetes Care 31 June (6) (2008) 1097-1104
50. Seidel M.C., Powell R.O., Zgibor J.C., Siminerio L.M., and Piatt G.A. Translating the Diabetes Prevention Program into an urban medically underserved community: a nonrandomized prospective intervention study. Diabetes Care 31 April (4) (2008) 684-689